This meta-analysis and systematic review suggests that patients with Parkinson disease who are carriers of LRRK2, GBA, and PRKN gene mutations show good motor advantages after STN DBS, comparable to patients with idiopathic Parkinson disease. This evidence concerns the gene PRKN and Parkinson disease.